BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20677583)

  • 1. Lacosamide, a newer antiepileptic.
    Patyar S; Medhi B
    Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide: new adjunctive treatment option for partial-onset seizures.
    Chung SS
    Expert Opin Pharmacother; 2010 Jun; 11(9):1595-602. PubMed ID: 20482307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacosamide: a review of preclinical properties.
    Beyreuther BK; Freitag J; Heers C; Krebsfänger N; Scharfenecker U; Stöhr T
    CNS Drug Rev; 2007; 13(1):21-42. PubMed ID: 17461888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
    Beydoun A; D'Souza J; Hebert D; Doty P
    Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide for the treatment of epilepsy.
    de Biase S; Gigli GL; Valente M; Merlino G
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):459-68. PubMed ID: 24479852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood.
    Gulati P; Cannell P; Ghia T; Bint L; Walsh P; Ghosh S; Nagarajan L
    J Paediatr Child Health; 2015 Aug; 51(8):794-7. PubMed ID: 25683595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide for the treatment of partial-onset seizures.
    Biton V
    Expert Rev Neurother; 2012 Jun; 12(6):645-55. PubMed ID: 22650166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
    Saussele T
    Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
    Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
    Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
    Degiorgio CM
    Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.
    Curia G; Biagini G; Perucca E; Avoli M
    CNS Drugs; 2009; 23(7):555-68. PubMed ID: 19552484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.
    Rastogi RG; Ng YT
    J Child Neurol; 2012 Apr; 27(4):492-5. PubMed ID: 22467791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in epilepsy treatment: lacosamide pharmacokinetic profile.
    Cawello W; Stockis A; Andreas JO; Dimova S
    Ann N Y Acad Sci; 2014 Nov; 1329():18-32. PubMed ID: 25167889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide for the treatment of epilepsy.
    Krauss GL; Edwards HB; Lin B
    Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
    Errington AC; Stöhr T; Heers C; Lees G
    Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
    Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
    J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
    García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
    Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.